Latvia vs Switzerland: Share of S. aureus infections resistant to methicillin
Latvia
3.8%
in 2022
Switzerland
4.1%
in 2022
Latvia rank
41st
Switzerland rank
39th
Share of S. aureus infections resistant to methicillin over time
- Latvia
- Switzerland
How they compare
Switzerland currently reports 4.1% against 3.8% in Latvia, a difference of 0.3%.
That makes Switzerland's figure about 1.1 times Latvia's.
The two have swapped places 4 times across 7 shared years of data; in 2016 it was Switzerland ahead.
Latvia ranks 41st and Switzerland ranks 39th of 45 countries.
Across the 2 decades both report, Latvia averaged higher in 1 and Switzerland in 1.
Head to head by decade
| Decade | Latvia | Switzerland | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 5.4% | 4.8% | 0.6% | Latvia |
| 2020s | 7.3% | 11.1% | 3.8% | Switzerland |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of s. aureus infections resistant to methicillin, Latvia or Switzerland?
- Switzerland, at 4.1% against 3.8% in Latvia as of 2022.
- What is the difference in share of s. aureus infections resistant to methicillin between Latvia and Switzerland?
- 0.3%, with Switzerland ahead.
- How many years of comparable data are there for Latvia and Switzerland?
- 7 years are reported by both, from 2016 to 2022.
- How do Latvia and Switzerland rank globally for share of s. aureus infections resistant to methicillin?
- Latvia ranks 41st and Switzerland ranks 39th of 45 countries.
- Where does this data come from?
- World Health Organization – processed by Our World in Data, published as Share of S. aureus infections resistant to methicillin. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested (%).